Ethnopharmacological relevance: Campomanesia lineatifolia Ruiz and Pav. (Myrtaceae) is a native edible species found in the Amazon Rainforest, commonly known as gabiroba. In Brazil, Campomanesia species are frequently used in traditional medicine for gastrointestinal disorders.
Introduction
Campomanesia lineatifolia Ruiz and Pav. (Myrtaceae), also known by several common names, such as gabiroba, guavira, or champa, is a native edible species found in the Amazon Rainforest in Brazil, Colombia, Peru, and Bolivia (D'Eeckenbrugge and Ferla, 2000) . The fruits of the Campomanesia species are widely used to make liqueurs, juices, and sweets (Lorenzi et al., 2006) . The leaves are traditionally employed as a medicine for dysentery, stomach problems, diarrhea (Pio Corrêa, 1952) , cistities and uretrites (D'ávila, 1910) , as well as hepatic disorders (Moraes, 1881) . They have also been used to reduce blood cholesterol and induce weight loss (Dickel et al., 2007) . Souza-Moreira et al. (2011) recently reported on the antidiarrheal activity of Campomanesia xanthocarpa. Ktafke et al. (2010) have demonstrated that Campomanesia xanthocarpa reduced total cholesterol and LDL levels in the blood of hypercholesterolemic patients. The same species brought about a significant decrease in blood glucose levels and hepatic glycogen loss and prevented potential histopathological alterations in the pancreas and kidneys in streptozotocin diabetic rats (Vinagre et al., 2010) . Moreover, the oral administration of the Campomanesia xanthocarpa extract at 400 mg/kg attenuated gastric mucosal lesions induced by ethanol in rats (Markman et al., 2004) . Antimicrobial activities of hexanic extracts and fractions of Campomanesia pubsenses and Campomanesia admantium fruits have also been reported in the literature (Cardoso et al., 2010) .
Studies concerning Campomanesia species have commonly identified flavonoids (Schmeda-Hirschmann, 1995; Pavan et al., 2009) , monoterpens, and sesquiterpens (Cardoso et al., 2008; Coutinho et al., 2009 ). However, phytochemical investigations of Campomanesia linetatifolia are rather limited (Bonilla et al., 2005; Osorio et al., 2006) , and no specific studies on in vivo biological assessments or the safety of this species can be found in the literature. The present work describes the antioxidant and gastroprotective activities and acute toxicity data of the ethanolic extract (EEC) and respective ethyl acetate fraction (AEFC) of Campomanesia linetatifolia. In addition, based on the total tannin and flavonoid contents, as well as the phytochemical analyses of the Campomanesia lineatifolia extracts and fractions, the present work also analyzes the compounds that may well contribute to the gastroprotective activity.
Material and methods

Plant material
Campomanesia lineatifolia leaves were collected in the state of Minas Gerais, Brazil (19 • 52 9.87 S; 43 • 58 12.04 W). The species was identified by Dr. Marcos Sobral from the Botany Department of Instituto de Ciências Biológicas at Universidade Federal de Minas Gerais (UFMG), Belo Horizonte. A voucher specimen (no. BHCB 150.606) was deposited at the UFMG Herbarium.
Drugs and chemicals
Pyrogallol was obtained from Merck (Brazil); 1,1-diphenyl-2-picrylhydrazyl, hide powder, quercetin, quercitrin, and catechin were purchased from Sigma-Aldrich (Brazil). Indomethacin was obtained from Merck, Sharp & Dohme (Brazil), cimetidine from SKF (Brazil), and sucralfate from Natures Plus Farm Ltda (Brazil). All other chemicals used in this study were of analytical grade.
Extraction and isolation
The Campomanesia lineatifolia leaves were dried at 40 • C/72 h with forced air circulation. The powdered dry leaves (400 g) were extracted using ethanol 96% by percolation at room temperature for 48 h. Evaporation of the solvent under vacuum yielded 94.4 g (23.6%) of dry extract (EEC). The dry EEC (40 g) was suspended in water (400 mL) and sequentially partitioned with four solvents of different polarity, thus yielding four fractions: hexane (2.6 g), CH 2 Cl 2 (2.4 g), EtOAc (5.6 g), and BuOH (10.7 g). Fractionation of EAFC (2.1 g) by High Speed Countercurrent Chromatography (HSCCC) was performed using a binary solvent system, Hexane:EtOAc:MeOH:H 2 O (0.6:4.0:0.7:1.0), in which the organic phase was the mobile phase, in turn producing quercitrin (29.1 mg) and catechin (52.6 mg). Isolated compounds were characterized by spectroscopic techniques, including UV-vis, IR, 1 H and 13 C NMR, COSY, DEPT-135, and HSQC. The known flavonoids were identified by comparison with reported physical and spectral data (MartinezRicha and Joseph-Nathan, 2003; Ceruks et al., 2007) .
Determination of total flavonoid content
The total flavonoid content was determined using the method adapted from Brazilian Pharmacopeia IV (Brazilian-Pharmacopeia, 2001 ). Briefly, dry plant material, EEC, and EAFC were hydrolyzed by refluxing in a boiling acid solution (20 mL acetone; 1 mL methenamine, 0.5% w/v; 7 mL HCl solution, 25% v/v) for 30 min.
After cooling, the flavonoid aglycones were exhaustively extracted using EtOAc. An aliquot of 10 mL of EtOAc extracted from each sample was added to 1 mL of AlCl 3 ·6H 2 O solution (2%, w/v). This mixture was combined with 14 mL of methanolic acetic acid solution (5%, v/v) and, after 30 min; the absorbances were read at 425 nm. The blank referred to the same solution without AlCl 3 ·6H 2 O reagent. Tests were carried out in triplicate. The total flavonoid content was calculated from the calibration curve of quercetin standard solutions ranging from 0.4 to 4.8 g/mL. Results were expressed in g of quercetin per 100 g of sample (%, w/w).
Determination of tannin content
The quantitative tannin content in samples was estimated using the method adapted from Brazilian Pharmacopeia IV (BrazilianPharmacopeia, 2002) . Briefly, dry plant material, EEC, and EAFC were diluted in water in known concentrations and boiled for 30 min under reflux and filtrated (sol 1). To 20 mL of the filtrate, 0.2 g of hide powder was added and stirred for 1 h (sol 2). A 5 ml aliquot of both solutions 1 and 2 were diluted in 25 mL of water. Finally, an aliquot of 5 mL of a sample solution was added to 2 mL of Folin-Denis reagent. This mixture was combined with 43 mL of Na 2 CO 3 solution and, after 3 min, the absorbances were read at 715 nm. The blank referred to the same solution without Folin-Denis reagent. Tests were carried out in triplicate. The tannin concentrations were calculated on the basis of the difference in the optical absorbance values of solutions 1 and 2. The total tannin content was calculated from the calibration curve of pyrogallol standard solutions ranging from 0.3 to 1.8 g/mL. Results were expressed in g of pyrogallol per 100 g of sample (% w/w).
In vitro antioxidant activity -DPPH assay
The free radical scavenging activity of EEC and EAFC was measured in vitro by means of a 1,1-diphenyl-2-picryl-hydrazyl (DPPH) spectrophotometric assay (Brandwilliams et al., 1995) . One mL of an ethanolic DPPH solution (0.3 mM) was added to 3 ml of extracts dissolved in ethanol at different concentrations (1.0, 2.5, 5.0, 7.5, 10.0, and 15.0 g/mL). After a 30 min incubation period at room temperature, the absorbance level was read by being compared to a blank solution (without sample) at 516 nm. Sample concentration, providing 50% inhibition (IC 50 ), was calculated using the linear regression method from the graph, plotting the inhibition percentage against the sample concentration. The inhibition mode for all samples was linear. Tests were carried out in triplicate, and quercetin was used as a positive control.
Pharmacology
Animals
Male Wistar rats (200-250 g) were used in this pharmacological study. To perform the acute toxicity assay, female Wistar rats (8-12 weeks) were used according to the OECD 423 (2002) guideline methodology. All rats were provided by the Animal Shelter from the School of Pharmacy at UFMG. The animals were fed a certified Nuvilab diet, had free access to tap water, and were left to adjust to their environment for five days before applying dosages. They were kept during all experiments under standard environmental conditions of temperature (25 ± 1 • C), humidity (70 ± 10%), and lighting (12 h light:12 h dark). Protocol was approved by the Local Animal Care Committee at UFMG (CETEA no. 52/2010, Brazil) , and all the experimental procedures were carried out in accordance with international guidelines for the care and use of laboratory animals. Table 1 Groups and treatment doses used in gastroprotective activity assays.
Evaluation of gastroprotective activity
The rats were fasted for 24 h prior to the experiment in wire mesh cages to avoid coprophagia. The animals had free access to water up to 1 h before the experiment. Ethanol-and indometacininduced gastric lesion experiments were performed during the same time of day to avoid variations due to diurnal rhythms of putative regulators of gastric function (Heeba et al., 2009 ). The rats were randomly divided into groups of six animals.
Each group received vehicle carboximetilcelulose (CMC) 0.5%, EEC, EAFC, cimetidine, or sucralfate, orally, through gastric gavage, 1 h before the oral administration of the aggressor agents: absolute ethanol 1 mL/200 g b.w. (Robert, 1979) or indomethacin 40 mg/kg (Nagai et al., 2009) . After 1 h (ethanol) and after 6 h (indomethacin), the animals were sacrificed, the stomachs were removed, and the gastric contents were collected. The stomachs were washed in icecold saline, opened along the great curvature, and fixed in buffered formalin (pH 7.2). The groups and the treatment doses are summarized in Table 1 .
Gastric pH
After having removed the stomach, a small incision was made near the pylorus to collect gastric juices. A pH measurement was performed, using tape pH indicators (Merck) (Jorge et al., 2004) .
Evaluation of macroscopic gastric lesion
After the fixation period, digital photos were taken of the stomachs using a Sony ® DSC-H50 9.1 megapixel digital camera at a distance of 5.7 cm from the gastric mucosa, with the zoom feature off. The quantitative analysis of gross hemorrhagic spots and bands (hemorrhagic zones) (Arisawa et al., 2006) was performed using the KS300 software from the Carl Zeiss image analyzer (Oberkochen, Germany). The pixels with shades of black and dark brown, referring to the hemorrhagic zones, were selected to create a binary image, and the area was measured in mm 2 . Gastroprotection was calculated as the percentage of decrease of the hemorrhagic zone area as compared to that of the control.
× of test group/hemorrhagic zone area (mm 2 )
× of control group (ethanol or indomethacin)] × 100
Microscopic and morphometric analysis of surface areas of necrosis (erosions) and ulcers
The entire glandular mucosa of each stomach was divided into four serial strips parallel to the limiting ridge (Fig. 1) . Tissue samples were dehydrated in ethanol series, diaphanized in xylol, and embedded in paraffin. Sections of 5 m in thickness were stained with periodic acid-Schiff (PAS). The specimens were analyzed using a 4× objective Axiolab Carl Zeiss light microscope (Oberkochen, Germany), and all damaged areas, including superficial or deep necrotic erosions and ulcers, were digitalized by means of a TK-1270/RGB JVC microcamera (Tokyo, Japan) attached to the microscope. All necrosis areas (m 2 ) of the four histological sections were measured using the KS300 software. The slides were also digitalized using a scanner (HP scanjet 2400) in 300 dpi resolution. The total area of histological sections (area of the gastric wall) was determined by selecting pixels in real image using KS300 (Fahel et al., 2010) . The values were expressed as the total necrosis area (m 2 ) per 45.3006 mm 2 of gastric wall (smallest analyzed gastric wall area).
Quantitative analysis of gastric mucus area
The same longitudinal sections were used to calculate the gastric mucus area. Thirty-two random fields (8 from each section) were analyzed for each stomach, using a 10× objective. PAS+ areas (m 2 ) were calculated by selecting pixels of PAS-stained mucosubstances (characteristic carmine colors), given the system's ability to delineate objects based on their color and intensity. All gastric mucosa pixels were also selected to calculate the total area of the gastric mucosa (m 2 ). The microscopic imaging methodology, image segmentation, and morphometric conditions were performed as described by Caliari (1997) . The Mucus Index (M.I.) was calculated by determining the ratio of the PAS+ area to the area of gastric mucosa. This index was analyzed as an indicator of the amount of gastric mucus.
Acute toxicity studies
Rats were fasted for one night prior to the administration of the drug. A total of six animals were used, which received either a vehicle (CMC 0.5%) or a single oral dose (2000 mg/kg, b.w.) of Campomanesia lineatifolia leaf extract (EEC or EAFC). After the administration of the drug, food was withheld for another 3-4 h. Animals were observed individually at least once in the first 30 min after dosing, periodically during the first 24 h (with special attention paid during the first 4 h), and daily thereafter for a period of 14 days. Daily cage-side observations included changes in skin and fur, in eyes and mucous membrane (nasal), as well as respiratory rate, heart rate, autonomic (salivation, lacrimation, perspiration, piloerection, urination, and defecation), and central nervous system (ptosis, drowsiness, gait, tremors, and convulsion) changes. Individual animal weights were determined shortly before the administration of doses and weekly thereafter. Food and water consumption were also evaluated. Mortality, if any, was determined over a 2-week period. At the end of the test, all animals were subjected to gross necropsy, and all pathological changes were recorded (OECD, 2002).
Statistical analysis
For phytochemical and in vitro antioxidant activity analyses, data were expressed as mean ± S.D., and as mean ± S.E.M. for in vivo evaluations (toxicology and gastroprotective activity). A value of P < 0.05 was considered statistically significant. Statistical evaluation was performed by one-way analyses of variance (ANOVA) followed by Tukey (phytochemical and antioxidant) or Newman-keus (in vivo determinations) tests for multiple comparisons. All analyses were performed using the GraphPrism5 statistical software.
Results
Phytochemical analysis and in vitro antioxidant activity
Phytochemical assays revealed the presence of flavonoids and tannins in the Campomanesia lineatifolia leaves, EEC and EAFC. The bioguided chromatographic fractionation of EAFC yielded the isolation of (+)-catechin (2R,3S)-5,7,3 ,4 -tetra-hidroxilflavan-3-ol (catechin) and quercetin 3-O-␣-ramnoside (quercitrin). The highest flavonoid content was observed in EAFC (9.3 ± 0.3%) (P < 0.05). The flavonoid content found in EEC and the dry plant material were 4.0 ± 0.1% and 1.0 ± 0.1%, respectively. The highest tannin content was observed in EEC (18.7 ± 0.1%) (P < 0.05). The tannin content Data are expressed as mean ± S.D.; n = 3. * P < 0.05 when compared to quercetin (one-way ANOVA followed by Tukey's test). ** P < 0.01 when compared to quercetin (one-way ANOVA followed by Tukey's test).
found in EAFC and the dry plant material were 16.5 ± 0.3% and 3.1 ± 0.1%, respectively. EEC, EAFC and the two isolated compounds reduced DPPH to a yellow colored product in a concentration dependent manner. The IC 50 values are shown in Table 2 . Since the EAFC fraction presented a greater antioxidant activity than did the Hex, CH 2 Cl 2 , and BuOH fractions (data not shown), this fraction was chosen, along with EEC, to be used in the gastroprotective activity and acute toxicity studies.
Gastric pH
In the absolute ethanol-induced gastric lesion model, as compared to the vehicle group, no significant differences in the gastric pH of the groups treated with sucralfate, EEC, and EAFC could be observed at any of the tested doses (pH = 3.1 ± 1.0). In this model, only cimetidine (pH = 7.7 ± 0.2) induced an increase in pH (P < 0.05). However, in the indomethacin-induced gastric lesion model, the gastric pH proved to be higher than that of the vehicle group in animals treated with cimetidine (pH = 4.9 ± 0.5), EAFC 800 mg/kg (pH = 4.5 ± 0.2), and EAFC 1200 mg/kg (pH = 4.5 ± 0.2) (P < 0.05).
Macroscopic gastric lesion evaluation (hemorrhagic zones)
Intragastric administration of ethanol led to the development of hemorrhagic bands in the glandular portion of the rats' gastric mucosa. The control group presented a mean hemorrhagic zone area of 90.7 ± 8.6 mm 2 . The treatment of the rats with EEC and EAFC (100-400 mg/kg) brought about a significant (P < 0.05) decrease in the gastric hemorrhagic zones in a dose dependent manner (EEC, r 2 = 0.75; FAEC, r 2 = 0.79). The hemorrhagic zone areas (mm 2 ) are presented in Fig. 2 (upper graph) . At the macroscopic level, EEC at doses of 100, 200, and 400 mg/kg demonstrated 68.8%, 93.7%, and 99.6% gastroprotection. Gastroprotection induced by EAFC at the same doses were 90.9%, 94.7%, and 99.9%, respectively. The positive control sucralfate (200 mg/kg) group provided a 98.6% gastroprotection. However, the cimetidine (50 mg/kg) exerted no effective gastroprotection (47.7%) in this model.
The intragastric administration of indomethacin at 40 mg/kg induced a gastric injury that could be viewed macroscopically as hemorrhagic spots in the glandular portion of the rats' gastric mucosa. The control group presented a mean hemorrhagic zone area of 11.78 ± 1.14 mm 2 . As EEC at a dose of 200 mg/kg produced no significant effect in this model (10.92 ± 0.99 mm 2 ) (P > 0.05), the tests were therefore performed using higher EEC, EAFC, and, positive control doses. The treatment of the rats with EEC and EAFC at doses of 400-1200 mg/kg triggered a significant (P < 0.05) decrease in the gastric hemorrhagic zones in the rats' gastric mucosa in a dose dependent manner (EEC, r 2 = 0.78; EAFC, r 2 = 0.72). The hemorrhagic zone areas (mm 2 ) are presented in Fig. 3 (upper graph) . At the macroscopic level, EEC at doses of 400, 800, and 1200 mg/kg demonstrated 67.0%, 89.2%, and 98.8% gastroprotection. The gastroprotection induced by EAFC at the same doses were 32.3%, 74.7%, and 98.1%, respectively. The positive control sucralfate (400 mg/kg) and cimetidine (100 mg/kg) groups provided 81.2% and 95.0% gastroprotection, respectively.
Microscopic gastric lesion evaluation (necrosis)
The microscopic appearance of necrosis regions in absolute ethanol treated rats revealed damaged areas down to deep layers of the mucosa. In the indomethacin model, the histopathologic analysis presents necrosis regions, loss of the normal mucosa architecture and the detachment of tissue, especially in the control group. In both models, the treatment of the rats with EEC, and EAFC caused a significant (P < 0.05) decrease in the necrotic area of the gastric mucosa. The necrosis areas (m 2 ) are represented in the lower graphs of Fig. 2 (ethanol model) and Fig. 3 (indomethacin model).
Morphometric analysis of mucus content in gastric mucosa
In the ethanol-induced gastric ulceration model, the EAFC 400 mg/kg treatment led to the development of a substantial continuous PAS stained (PAS-positive) mucous gel layer which covered the surface of the gastric mucosa. Similar to the vehicle group, a bright, carmine-stained area covering the mucosa and extending up to the gastric pits could be observed (Fig. 4) . Quantitative analysis revealed that EAFC, at a dose of 400 mg/kg, as compared to control group (0.018 ± 0.005) and groups treated with reference drugs of sucralfate (0.021 ± 0.004) and cimetidine (0.022 ± 0.007), produced a significant increase (P < 0.05) in the mucus index (M.I.) (0.104 ± 0.003). Moreover, the M.I. of animals that received EAFC at a dose of 400 mg/kg was similar to that of the vehicle group (0.122 ± 0.025) (P > 0.05).
Neither EEC, nor EAFC, was able to reestablish the gastric mucus levels in the indomethacin-induced model. In this model, cimetidine and sucralfate also failed to exert any effect on M.I.
Acute toxicity studies
A single oral dose of EEC or EAFC (2000 g/kg) produced neither moderate, nor severe signs of toxicity in the treated animals. Within the first hour after oral administration, a slight reduction in the locomotory behavior (lethargy) of EAFC-treated rats could be detected; however, this condition proved to be reversible by the end of the second hour. After 8 h, the EEC-and EAFC-treated groups displayed mild constipation, which proved to be reversible within 24 h. No significant changes in the consumption of food and water could be observed in the EEC and EAFC groups, when compared to the control. After 14 days, no mortality, nor any significant changes in body weight or in the macroscopic aspects of the organs, could be observed.
Discussion
The present study evaluated both the flavonoid and tannin content as well as the in vitro antioxidant and in vivo gastroprotective activities of Campomanesia lineatifolia leaf extract and fractions. EEC and EAFC treatment significantly inhibited the development of gastric lesions induced by the oral administration of ethanol or indomethacin in rats. In addition, single dose safety could be deduced from acute oral toxicological tests. Prior literature firmly defends that flavonoids, in addition to their antioxidant properties, exhibit multiple biological results, including anti-inflammatory and antibacterial effects. Moreover, they are able to inhibit lipid peroxidation and improve increased capillary permeability (Procházková et al., 2011) . Recent studies have also reported on anti-ulcer and gastroprotective properties of plant extracts rich in flavonoids, phenolic acid derivatives, and tannins (Arawwawala et al., 2010; Vasconcelos et al., 2010) that present a high free-radical scavenger potential (Mayer et al., 2009; Eswaran et al., 2010) . In the present study, the high polyphenolic content in EEC and EAFC suggests that this group of substances, particularly cathequin and quercitrin, which were isolated and identified in ethanolic extract and fractions, may well be one of the active compounds of Campomanesia lineatifolia leaves. In addition, the flavonoid content of this study presented a positive agreement with the antioxidant capacity of EEC and EAFC.
The present results show a quantitative decrease in hemorrhagic zones in both ethanol-and indomethacin-induced gastric lesion models. The efficacy of Campomanesia lineatifolia was further substantiated by quantitative histological findings, where a marked decrease in areas of gastric mucosal necrosis could be observed.
Exposure of gastric mucosa to ulcerogenic compounds, like ethanol, has been shown to affect cellular integrity. These changes are commonly associated with oxidative stress and mitochondrial damage, due mainly to local effects, coupled with the formation of free radicals and reactive oxygen species (ROS) (Repetto and Llesuy, 2002) . Furthermore, the administration of ethanol increases lipid peroxidation, depletes mucus on the gastric surface, and disturbs microcirculation (Rozza et al., 2011) . The present study demonstrated a more favorable response produced by EAFC, as compared to EEC, at doses of 100 mg/kg in an ethanol-induced gastric lesion model. The results suggest that EAFC higher flavonoid content and higher antioxidant activity did in fact contribute to the scavenging of the free radicals produced by the metabolism of ethanol, thereby preventing gastric damage.
Overall, the preventive effects of antisecretory agents on gastric mucosal injuries caused by ethanol are minimal, whereas those of gastroprotective drugs proved to be considerable (Arisawa et al., 2006 ). Therefore, the good level of gastric protection demonstrated by oral treatment with EEC and EAFC, as compared to treatments with cimetidine and sucralfate, in ethanol-induced gastric lesion models suggests that the extracts do in fact exert a gastroprotective effect by enhancing the mucosal defense.
In the present study, the administration of EAFC 400 mg/kg significantly increases the mucus index (M.I.) in ethanol-treated rats. Several studies have shown the importance of gastric mucus in gastroprotection (Morini et al., 1997; Phillipson et al., 2008; Moraes et al., 2009) . As neutral glycoproteins (PAS+) are the most abundant and possibly the most important glycoprotein in the gastric mucosa, it can be assumed that a quantitative restitution of M.I. represents a return to a physiological condition, and thus a recovery of the defensive capacity against aggression (Delalastra et al., 1994) . Therefore, the present results suggest that an increase in the mucus secretion may well play a key role in the gastroprotective mechanisms of Campomanesia lineatifolia.
Treatments with EEC and EAFC significantly reduce indomethacin-induced gastric lesion. Although direct topical injury may occur, the major mechanism through which nonsteroidal anti-inflammatory drugs (NSAID) cause ulcers and gastrointestinal complications is thought to be systemic, by inhibiting the COX-mediated prostaglandin synthesis. However, other prostaglandin-independent mechanisms are also important in ulcer pathogenesis (Musumba et al., 2009 ). The present study's results suggest that EEC and EAFC, due to their gastroprotective effects in the indomethacin model, possess a relevant therapeutic potential within alternative treatments aimed at reducing NSAID gastrotoxicity.
The present study demonstrated depleted levels of gastric mucus in rats with indomethacin-induced gastric lesions, including those treated with higher doses of EEC and EAFC, as well as with the reference drugs of cimetidine and sucralfate, despite the gastroprotection. Mucus layer is an important target of indomethacin gastrotoxicity, which is, in part, associated with ROS generation. The formation of these species occurs in the mucus layer, at the interface, or in the intracellular compartment of epithelial cells (Utsumi et al., 2006) . Phillipson et al. (2008) reported that prostaglandins stimulated mucus secretion in rats, resulting in an increased thickness of the mucus layer, while pretreatment with indomethacin at a low dose (3 mg/kg) decreased both the mucus secretion and the thickness of this layer.
In contrast to the ethanol model, the indomethacin model, at lower evaluated doses, presented a more positive response when EEC treatment, as compared to EAFC treatment, was applied. This could be explained, at least in part, by the greater complexity of EEC as compared to EAFC. Evidence shows that total or partial plant extracts often present a higher level of pharmacologic activity than do isolated compounds (Wagner et al., 2010) . Therefore, synergism can occur, resulting in a higher activity of EEC within this model. In addition, the present study's results show higher EEC tannin contents, which runs in line with prior literature that has reported on the gastroprotective activity of plant extracts that are rich in tannins Vasconcelos et al., 2010) . These polyphenols are potent scavengers of peroxyl radicals that can interact with mucus proteins, in turn improving their cytoprotective effects by forming a protein lining over the gastrointestinal mucosa (Okuda, 2005) .
In the indomethacin model, an increase in the gastric pH could be observed not only in cimetidine, which is an antisecretory agent (Schubert and Peura, 2008) , but also in higher doses (800 and 1200 mg/kg) of EAFC-treated rats. It has been reported that some flavonoids, including catechin and quercitrin, suppress gastric acid secretions primarily by inhibiting gastrin and histamine (Sato et al., 2002; Mota et al., 2009 ). Furthermore, Ghayur et al. (2007) reported the antispasmodic and vasodilatator activities of catechin in rat stomachs, which may well be important in the maintenance of normal mucosal blood flow and gastric integrity. As catechin and quercitrin were the majority substances in EEC and EAFC, it is possible that these mechanisms could contribute to the pharmacological basis for the efficacy of Campomanesia lineatifolia extracts in gastrointestinal disorders; however, further studies are warranted to confirm this hypothesis.
The present study was the first of its kind to investigate the acute toxicity of Campomanesia lineatifolia in rats. The absence of death and the lack of severe alterations in behavior and clinical signs indicate the acute oral safety of Campomanesia lineatifolia.
Conclusion
In conclusion, the results of the present study show that Campomanesia lineatifolia extracts of EEC and EAFC protect the gastric mucosa against ethanol-and indomethacin-induced gastric lesions. The gastroprotective effects appear to be related to their antioxidant properties and polyphenolic contents. The present study also presents a morphometric methodology to quantify the macroscopic and microscopic lesions, as well as the area covered by the gastric mucus, which can be used to evaluate the gastroprotective function in other studies with similar products.
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